Skip to content

Designed around practical constraints

A focused execution layer for community hospitals.

Cairava starts with a hospital-approved heart-failure pathway, explicit owners, and a contained 30-day workflow—so limited teams can make follow-through more reliable without a platform overhaul.

A contained execution layer
Authoritative sourceHospital systemsApproved plan · staff workflows
Focused transition episodeCairava · 30 daysPatient next steps · team exceptions

No rip-and-replace model

A strong first fit

Focused enough to move. Important enough to matter.

The first design partnership is intended for an independent or small-system hospital with a visible heart-failure transition gap and a sponsor who can bring the operating team together.

Design-partner profile
0125–150 bedsIndependent or small-system community hospital
02Heart failure firstA contained condition pathway with visible transition work
03Named sponsorNursing, quality, case management, or transition leadership
04Practical scopeA preference for staged workflow change over a platform overhaul

A staged launch path

Earn complexity one approved step at a time.

The sequence begins with the workflow and clinical boundary, not an integration checklist or a fixed implementation promise.

01

Map the current handoff

Identify the packet, calls, spreadsheets, roles, and unresolved loops that define the transition today.

02

Approve the pathway

Agree on content, ownership, review points, escalation rules, and what the system must never do.

03

Test with synthetic episodes

Validate the workflow, accessibility, privacy surfaces, and audit trail before any clinical deployment.

04

Measure follow-through

Review task movement, barrier resolution, human workload, and loop closure against the agreed baseline.

Work alongside current systems

The EHR stays authoritative. Execution becomes visible.

Cairava sits between the documented discharge plan and what happens at home. It does not become a new clinical source of truth, and every production input and connection is approved with the partner hospital.

Source

Hospital-approved plan

Content and instructions retain their source, review state, and clinical meaning.

Continuity

Local drafts and queued work

Local state supports continuity; it does not resolve clinical conflicts or rewrite the source plan.

Expansion

Progressive connectivity

Connectivity expands only after the workflow, permissions, security controls, and owners are agreed.

Named EHR support and deployment timelines are confirmed per partner; this page does not claim a live integration.

Built around the operating team

No single department can close the transition alone.

01

Executive sponsor

Sets the outcome, scope, and accountability for the work.

02

Clinical owner

Approves pathway meaning, boundaries, and escalation decisions.

03

Operational lead

Maps current work and defines ownership across the episode.

04

Technical partner

Approves access, security, and the staged connection path.

Questions, clearly answered

What hospital teams usually ask first.

Is Cairava only for hospitals with a specific EHR?

No specific integration is claimed as available by default. Cairava is designed to keep the hospital source system authoritative and to define an approved input path with each design partner.

Does a first deployment require replacing current workflows?

No. The first step is to map the current handoff and contain the transition workflow. Technical and operational scope expands only after the hospital approves it.

Which team usually sponsors the work?

The operational sponsor is typically nursing, quality, case management, population health, or a transition-of-care leader with authority to align the participating teams.

Can the model expand beyond heart failure?

The architecture is intended to support reusable condition pathways, but expansion follows validation of the heart-failure workflow and requires separate clinical approval.

A practical first conversation

Bring the workflow you have today.

We’ll look at the current handoff, the team that owns it, and whether a focused heart-failure design partnership is a fit.